NTRK3 Fusion Positive
Drug | Drug Name | Drug Description |
---|---|---|
DB14723 | Larotrectinib | A kinase inhibitor used to treat solid tumors with neurotrophic receptor tyrosine kinase gene fusion, are metastatic, high risk for surgery, or have no alternative treatments. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11791 | Capmatinib | 2 | Terminated | 1 |
DB09063 | Ceritinib | 2 | Terminated | 1 |
DB11986 | Entrectinib | 2 | Terminated | 1 |
DB08896 | Regorafenib | 2 | Terminated | 1 |